Adaptive Bleeding Control Systems for Extreme Environments

Publication ID: 24-11857788_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Bleeding Control Systems for Extreme Environments,” Published Technical Disclosure No. 24-11857788_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857788_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,788.

Summary of the Inventive Concept

This inventive concept discloses specialized systems and methods for reducing bleeding in patients under unique operational environments, such as high-altitude medical emergencies, natural disasters, high-security situations, search and rescue operations, and medical evacuations.

Background and Problem Solved

The original patent, 'Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation', provides a general approach to preventing and/or treating bleeding in a subject. However, it does not address the specific challenges posed by extreme environments, where conventional bleeding control methods may be ineffective or impractical. This inventive concept adapts the original patent's principles to create specialized solutions for these niche situations.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of systems and methods tailored to specific extreme environments. For example, a portable, low-oxygen-operable apparatus can be used during high-altitude medical emergencies. A waterproof apparatus can be employed during natural disasters. An apparatus integrated with a surgical table can be used in high-security environments. A wearable, extreme-weather-resistant device can be used during search and rescue operations. A handheld, vital-sign-feedback-enabled device can be used during medical evacuations. Each of these variations incorporates the original patent's coordinated trigeminal and vagal nerve stimulation principles, adapted to the specific operational constraints and requirements of the target environment.

Novelty and Inventive Step

The new claims introduce novel, non-obvious adaptations of the original patent's principles to address the unique challenges of extreme environments. These adaptations include specialized apparatus designs, operating modes, and control systems that enable effective bleeding control in situations where conventional methods are inadequate.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include, but are not limited to, systems for use in extreme temperatures, high-radiation environments, or confined spaces. Variations could also include different stimulation protocols, electrode configurations, or power sources tailored to specific operational scenarios.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including emergency medical services, search and rescue, military operations, and disaster relief. The market for these specialized bleeding control systems is substantial, given the growing need for effective medical solutions in extreme environments.

Field of Art

Biomedical engineering focused on non-invasive nerve stimulation techniques for hemostasis and physiological control, requiring expertise in electrical stimulation, neuroanatomy, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced degree, knowledge of neurological stimulation techniques, understanding of nerve mapping, and experience designing wearable medical electronics

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's core principles of coordinated trigeminal and vagal nerve stimulation for bleeding control represent a generalizable technique that can be readily adapted to various environmental and operational contexts. The PTD's variations represent predictable engineering modifications that extend the fundamental stimulation methodology to specific use cases by applying known design adaptation strategies. These adaptations involve standard engineering practices of environmental ruggedization, interface modification, and operational context optimization.

Obvious Combinations & Variations

Source Patent Element
Electrical stimulation apparatus worn on head/neck with multiple electrodes targeting trigeminal and vagal nerves
PTD Variation
Waterproof apparatus for natural disaster scenarios with identical nerve stimulation principles
Obviousness Reasoning
Adapting device materials and sealing for water resistance represents a routine engineering design choice with predictable implementation techniques
Source Patent Element
Non-invasive electrical stimulation system for hemostasis control
PTD Variation
Low-oxygen environment operational mode for high-altitude medical emergencies
Obviousness Reasoning
Modifying electronic component specifications and power management to function in reduced oxygen environments is a standard engineering optimization process
Source Patent Element
Wireless communication circuitry for device control and monitoring
PTD Variation
Real-time vital sign feedback integration for medical evacuation scenarios
Obviousness Reasoning
Incorporating physiological monitoring into existing wireless communication infrastructure represents a known and predictable technical enhancement
Source Patent Element
Periodic electrical nerve stimulation protocol
PTD Variation
Stimulation interval adaptation based on environmental and patient-specific parameters
Obviousness Reasoning
Dynamically adjusting stimulation parameters based on contextual inputs is a standard control system design approach with predictable implementation strategies
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would have been obvious to a person having ordinary skill in the art at the time of invention, as they represent straightforward adaptations of the fundamental nerve stimulation methodology disclosed in US Patent 11857788, employing standard engineering design techniques to extend the core technological principles to diverse operational contexts.

Original Patent Information

Patent NumberUS 11,857,788
TitleMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Assignee(s)THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH